PHAT
PHAT clinical trials: Phathom Pharmaceuticals, Inc.
Every trial on ClinicalTrials.gov where Phathom Pharmaceuticals, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 18
- Trials linked
- 15
- As lead sponsor
- 3
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
PHAT on the catalyst calendar · PHAT registry changes
- Primary completion Oct 20, 2027Sponsor estimatePhase 3NCT07752407A Study to Evaluate the Efficacy and Safety of Vonoprazan 10 mg Compared to Placebo for Relief of Episodic Heartburn in Participants...Phathom Pharmaceuticals, Inc. · Symptomatic Non-erosive Gastroesophageal Reflux DiseaseRecruitingPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 11, 2026ActualPhase 2NCT06851559A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg...Phathom Pharmaceuticals, Inc. · Eosinophilic EsophagitisActive, not recruitingPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2034Sponsor estimateNo phase registeredNCT06660342A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their OffspringPhathom Pharmaceuticals, Inc. · Erosive EsophagitisRecruitingPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 5, 2025ActualPhase 1NCT06831344A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and...Phathom Pharmaceuticals, Inc. · Healthy VolunteersCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2023ActualPhase 1NCT05343364A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal...Phathom Pharmaceuticals, Inc. · Gastroesophageal RefluxCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 13, 2024ActualPhase 1NCT06391177A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or...Phathom Pharmaceuticals, Inc. · Erosive EsophagitisCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 16, 2024ActualPhase 1NCT06106022A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux DiseasePhathom Pharmaceuticals, Inc. · Gastroesophageal Reflux DiseaseCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 21, 2022ActualPhase 3NCT05195528A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo for Relief of Heartburn in Participants With Symptomatic...Phathom Pharmaceuticals, Inc. · Non-Erosive Gastro-Esophageal Reflux DiseaseCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 1, 2022ActualPhase 1NCT05366738A Study to Determine the Bioavailability of Vonoprazan Sprinkle Capsules on Pudding or on Applesauce Relative to a Vonoprazan Tablet in...Phathom Pharmaceuticals, Inc. · Healthy VolunteersCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 16, 2021ActualPhase 2NCT04799158A Study to Evaluate the Efficacy and Safety of Vonoprazan Compared to Placebo in Participants With Symptomatic Non-Erosive...Phathom Pharmaceuticals, Inc. · Non-Erosive Gastro-Esophageal Reflux DiseaseCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 29, 2021ActualPhase 3NCT04124926Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive EsophagitisPhathom Pharmaceuticals, Inc. · Erosive EsophagitisCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 12, 2021ActualPhase 1NCT04729101Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Vonoprazan and Lansoprazole in Healthy ParticipantsPhathom Pharmaceuticals, Inc. · Healthy ParticipantsCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2020ActualPhase 1NCT04545944Evaluation of Effect of Vonoprazan on Midazolam Pharmacokinetics in Healthy ParticipantsPhathom Pharmaceuticals, Inc. · Healthy VolunteersCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 10, 2021ActualPhase 3NCT04167670Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori InfectionPhathom Pharmaceuticals, Inc. · Helicobacter Pylori InfectionCompletedPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 7, 2021Sponsor estimatePhase 1NCT04558216Evaluation of Effect of Rifampin on the Pharmacokinetics of Vonoprazan in Healthy ParticipantsPhathom Pharmaceuticals, Inc. · Healthy ParticipantsWithdrawnPHATLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2028Sponsor estimatePhase 4NCT07788742Efficacy of Potassium-Competitive Acid Blockers in Barrett's Esophagus (PCAB BE Study)University of North Carolina, Chapel Hill · Barrett EsophagusRecruitingPHATCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 14, 2026ActualPhase 4NCT07224048Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2University of Miami · H. Pylori InfectionCompletedPHATCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 9, 2026ActualPhase 4NCT07224035Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1University of Miami · H Pylori InfectionCompletedPHATCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 18 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner